Publication
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer
Anne JOUINOT, Guillaume ASSIE, Rossella LIBE, Martin FASSNACHT, Thomas PAPATHOMAS, Olivia BARREAU, Bruno DE LA VILLEON, Simon FAILLOT, Nadim HAMZAOUI, Mario NEOU, Karine PERLEMOINE, Fernande RENE-CORAIL, Stéphanie RODRIGUEZ, Mathilde SIBONY, Frédérique TISSIER, Bertrand DOUSSET, Silviu SBIERA, Cristina RONCHI, Matthias KROISS, Esther KORPERSHOEK, Ronald DE KRIJGER, Jens WALDMANN, Detlef K BARTSCH, Marcus QUINKLER, Magalie HAISSAGUERRE, Antoine TABARIN, Olivier CHABRE, Nathalie STURM, Michaela LUCONI, Franco MANTERO, Massimo MANNELLI, Regis COHEN, Véronique KERLAN, Philippe TOURAINE, Gaelle BARRANDE, Lionel GROUSSIN, Xavier BERTAGNA, Eric BAUDIN, Laurence AMAR, Felix BEUSCHLEIN, Eric CLAUSER, Joel COSTE, Jérôme BERTHERAT
The Journal of Clinical Endocrinology & Metabolism, December 2016, Endocrine Society
DOI: 10.1210/jc.2016-3205